drugset / Trial / NCT06155513

Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

NCT06155513 ↗

Terminated 7 enrolled SCF Pharma
Non-randomizedSequentialOpen-labelBasic science

Summary

This exploratory study aims to verify the impact on the severity of eczema as well as the prebiotic potential of a daily application of Omega-3 serum and cream on a skin with eczema. This study will also collect data on possible adverse effects of the products. Sixteen participants will be enrolled in this study and will be divided in two groups of 8 subjects that will receive two different treatments for forty-two days. The baseline condition will serve as a control for the effects observed after treatment on the targeted eczema area.

Timeline

Start
2023-12-20
Primary completion
2025-11-05
Completion
2025-11-05

Outcome

Outcome not reported

Stopped: “There has been an important change to the product formulation.”

Drugs

EvaluationDrugModalityDoseRoute
Subject glyceryl Eicosapentaenoate Unknown — Topical

Indications